AstraZeneca is making a bold leap with a $15 billion investment in China through 2030, cementing its role as a leader in next-generation innovative medicine and expanding its presence in one of the world’s fastest-growing healthcare markets
Browsing: AstraZeneca
AstraZeneca has revealed thrilling plans for a full US stock market listing, assuring investors that its UK headquarters will stay firmly rooted. This bold strategy aims to boost access for US investors while proudly preserving its rich British heritage